StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

BioLineRx's enterprise value was $8.82M on Nov 11, 2026, against $4.22M a year earlier. Over the last 5 years it ranged from -$578.21K to $86.88M, with a median of $20.26M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$8.82M+212.7%
2025Dec 31, 2025$2.82M-80.9%
2024Dec 31, 2024$14.78M-80.0%
2023Dec 29, 2023$73.98M+465.2%
2022Dec 30, 2022$13.09M-35.4%
2021Dec 31, 2021$20.26M-7.7%
2020Dec 31, 2020$21.94M+60.0%
2019Dec 31, 2019$13.71M-59.2%
2018Dec 31, 2018$33.65M-42.8%
2017Dec 29, 2017$58.82M+40.9%
2016Dec 30, 2016$41.75M–

More BioLineRx figures

See a number that looks wrong?